A carregar...
Dendritic cell-glioma fusion activates T lymphocytes by elevating cytotoxic efficiency as an antitumor vaccine
BACKGROUND: Hybrid cells produced by fusions of tumor and dendritic cells (DC) have demonstrated remarkable efficacy for priming the anti-tumor immune response. In the current study, we examined the antitumor activity of cytotoxic T lymphocytes (CTLs) primed in response to a tumor vaccine comprising...
Na minha lista:
| Publicado no: | Cent Eur J Immunol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Polish Society of Experimental and Clinical Immunology
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4439993/ https://ncbi.nlm.nih.gov/pubmed/26155134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceji.2014.45935 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|